Every PMCPA ruling since 2005 — searchable and filterable by company, clause, and ABPI Code version.
Case Library Membership
Search free — but unlock advanced filters to find every case involving a specific company or clause.
Already a member? Sign in →
Case Library Membership
inc. VAT
inc. VAT · cancel any time
Secure payment via Stripe
Need access for your team?
Company licences available for compliance teams, medical affairs, and training programmes.
Get a team quote →1,930 cases found
Complaint alleged Forxiga ‘Prescribing & Dosing’ webpage omitted “critical” SPC warnings for moderate renal impairment (PTH increase, hypotension). Panel ruled no breach…
Two downloadable documents on Novartis’ HCP portal contained outdated Entresto prescribing information (May 2021 and June 2020) while the webpage PI was…
ABN slide deck and summary for a natalizumab biosimilar were ruled to go beyond permitted advance budgetary notification and amount to pre-authorisation…
A LinkedIn sponsored message promoting Ogluo (glucagon) was received by a non-HCP. The Panel found public promotion plus missing INN at first…
AAA’s RLT Hub stated Pluvicto was not licensed in Northern Ireland after EMA approval. PMCPA found the statement inaccurate/out-of-date and criticised website…
PMCPA found Janssen breached Clauses 5.1 and 6.1 (x3) over a PAH symposium video: relative risk shown without absolute risk, ARR mislabelled,…
A HCP complained a Blenrep promotional email was unsolicited and imbalanced. The Panel found the recipient had opted in via a third-party…
Roche funded a patient organisation website update. PMCPA found the declaration of support wasn’t apparent from the start and the written grant…
A US-facing LinkedIn post about an FDA-approved lung cancer combo was liked/commented on by 14 UK-based AstraZeneca employees, triggering ABPI Code breaches…
PMCPA found Valneva’s HCP “Valneva in Partnership” site promoted its Japanese encephalitis vaccine (Ixiaro) despite no product name, and breached Clause 12.1…
Five Observer articles alleged Novo Nordisk used payments, grants and PR to shape the obesity debate and influence NICE/NHS. PMCPA assessed multiple…
Pfizer UK posted three public tweets linking to a Pulse Today sponsored article. Panel found the article not promotional and no POM…
A senior UK Pfizer employee retweeted a US colleague’s tweet claiming 95% efficacy for a COVID-19 vaccine candidate before UK authorisation, with…
Complaint alleged Novo Nordisk funded an obesity practitioner’s salary to induce prescribing and influenced local liraglutide criteria. Panel and Appeal Board found…
Complaint alleged Rinvoq dosing web copy implied it could be taken with any food (incl. grapefruit) despite SPC advice to avoid grapefruit.…
Our PMCPA rulings expert has knowledge of over 1,900 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.
